journal article·1985-01

Iron detoxification by haemoperfusion through deferoxamine-conjugated agarose-polyacrolein microsphere beads

David Horowitz, Shlomo Margel, Tuvia Shimoni

Biomaterials· Volume 6· Issue 1
Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Iron Metabolism and Disorders · Hemoglobinopathies and Related Disorders · Hemoglobin structure and function

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (56)

Show source-provided references
1. Iron overload — clinical and pathologic aspects in pediatrics
2. Iron in the heart. Etiology and clinical significance10.1016/0002-9343(71)90240-3 ↗
3. Clinical consequences of acquired transfusional iron overload in adults10.1056/NEJM198102053040603 ↗
4. Absorption and excretion of iron10.1016/S0140-6736(00)56469-1 ↗
5. Clinical removal of iron10.1146/annurev.me.33.020182.002453 ↗
6. Idiopathic hemochromatosis, an iron storage disease. A. Iron metabolism in hemochromatosis10.1097/00005792-195512000-00001 ↗
7. Acute iron poisoning in children
8. Treatment of iron overload with parental deferoxamine
9. Iron overload — clinical and pathological aspects
10. Non-specific serum iron in thalassemia: an abnormal serum iron fraction of potential toxicity10.1111/j.1365-2141.1978.tb03662.x ↗
11. Storage iron regulation
12. Long-term results of venesection therapy in idiopathic haemochromatosis
13. Long-term chelation therapy in thalassaemia major: effect on liver concentration, liver histology and clinical progress10.1136/bmj.2.5909.16 ↗
14. Advances in the use of iron chelating agents for the treatment of iron overload
15. Stoffwechselprodukte von actinomyceten10.1002/hlca.19600430732 ↗
16. Treatment of iron overload in adults with continuous parental desferrioxamine10.1016/0002-9343(77)90551-4 ↗
17. Ocular toxicity of high-dose intravenous desferrioxamine10.1016/S0140-6736(83)90170-8 ↗
18. Treatment of hemodialysis hemosiderosis with desferrioxamine
19. Effect of desferrioxamine on removal of aluminium and iron by coated charcoal haemoperfusion and haemodialysis10.1016/S0140-6736(83)91039-5 ↗
20. Polyacrolein microspheres as a new tool in cell biology10.1242/jcs.56.1.157 ↗
21. Novel effective immunoadsorbents based on agarose-polyaldehyde microsphere beads10.1016/0003-2697(83)90384-6 ↗
22. Hemoperfusion for detoxification of mercury. A model: treatment of severe mercury poisoning by encapsulated chelating spheres
23. The Iron Reagents
24. Improved direct specific determination of serum iron and total iron-binding capacity10.1093/clinchem/26.2.327 ↗
25. Zur kenntnis von desferrioxamin B10.1002/hlca.19630460433 ↗
26. Polymer-drug grafts for iron chelation10.1080/00222337608068101 ↗
27. The role of ascorbic acid in the turnover of storage iron
28. Effect of dose, time, and ascorbate on iron excretion after subcutaneous desferrioxamine10.1016/S0140-6736(77)92279-6 ↗
29. Acute intenstinal iron intoxication. I. Iron absorption, serum iron and autopsy findings
30. The rabbit as a model for hemoperfusion: surgical preparation and use10.1258/002367784780864947 ↗
31. Dialysis and hemoperfusion of drugs and toxins
32. Hemoperfusion in drug intoxication: clinical and laboratory aspects10.3109/03602537808993778 ↗
33. Semipermeable microcapsules10.1126/science.146.3643.524 ↗
34. Semipermeable aqueous microcapsules10.1139/y66-013 ↗
35. A convenient hemoperfusion micro-apparatus over charcoal for the treatment of endogeneous and exogenous intoxications: its use as an effective artificial kidney
36. The use of hemoperfusion in children10.1016/S0031-3955(16)34227-4 ↗
37. Behaviour of trace metals during hemoperfusion
38. Agaroseencapsulated adsorbents, a new material for hemoperfusion
39. Porath, J., Laas, T. and Janson J., Agar derivatives for chromatography, electrophoresis and gel-bound enzymes. III. Rigid agarose gels cross-linked with divinylsulphone, J. Chromat. 975, 103, 49–6210.1016/S0021-9673(00)83800-5 ↗
40. A novel iron-chelating graft polymer10.1080/10601327308060480 ↗
41. Schultz · 1967 · Vol. 1
42. Reactions of high molecular weight polyacrolein
43. Hydroxamatkomplex10.1002/hlca.19630460434 ↗
44. Sodium borohydride and amine-boranes, commercially important reducing agents10.1351/pac197749060733 ↗
45. Agarose polyacrolein microsphere beads10.1016/0014-5793(82)80196-8 ↗
46. Agarose-polymeric microsphere beads: specific new adsorbents for hemoperfusion
47. A new immunoadsorbent for hemoperfusion, agarose-polyacrolein microsphere beads
48. Extracorporeal removal of specific antibodies by hemoperfusion through the immunoadsorbent agarose-polyacrolein microsphere beads: a model for the removal of anti-BSA10.1002/jbm.820180916 ↗
49. Cell fractionation with affinitiy ligands conjugated to agarose-polyacrolein microsphere beads10.1242/jcs.62.1.149 ↗
50. Some coordinate compounds in biochemistry
51. Plasma radioiron kinetics in man: explanation for the effect of plasma iron concentration
52. Iron metabolism in humans and plants
53. The effects of intensive and prolonged administration of iron parenterally in animals
54. Studies in iron transportation and metabolism. X. Longterm iron overload in dogs
55. Continuous subcutaneous administration of deferoxamine for iron overload10.1056/NEJM197708252970804 ↗
56. Mechanism of desferriox-amine-induced iron excretion in thalassaemia10.1111/j.1365-2141.1979.tb03704.x ↗